56F-23231-46816
3 vaccinations
2 coded responses
13 check-ins
1 free-text entry
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 032 / NH
- Registered
- 2022-07-23
- Relationship
- Child or adolescent in my care
- Guardian
- UM4-19675-65817
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-30
Dose 1 — Pfizer-BioNTech
-
2021-12-21
Dose 2 — Pfizer-BioNTech
-
2022-07-21
Dose 3 — Pfizer-BioNTech
-
2022-07-23
Registered in v-safe
-
2022-07-23
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2022-07-24
- 2022-07-25
- 2022-07-26
- 2022-07-27
-
2022-07-28
Health check-in — day 7, dose 3, dependentFeeling: Fair · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-08-04
- 2022-08-11
- 2022-08-18
- 2022-08-25
- 2022-09-01
-
2022-10-22
Survey response — 3 months, dose 3, dependentMedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend schoolFree text: Several colds. All Covid neg.MedDRA releases: 2024-11 · check-in free text available
-
2023-01-19
Survey response — 6 months, dose 3, dependentMedDRA: COVID-19, Gait inability, Upper respiratory tract infection, Viral myositis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-19
Report sent to call center — 6 months, dose 3, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-01-20
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-30 | Pfizer-BioNTech | No |
| 2 | 2021-12-21 | Pfizer-BioNTech | No |
| 3 | 2022-07-21 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 12 — 3 months, dose 3, dependent
Symptoms: Several colds. All Covid neg.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Gait inability | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SD | Viral myositis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release